Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 17 symbols : Jnj save search
Global $400+ Mn Dry Eye Treatment Devices Market to 2028 Featuring Lumenis; ESW Vision; Johnson & Johnson; MiBo Medical; Alcon; and Sight Sciences
Published: 2021-09-17 (Crawled : 22:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
dry eye treatment eye device
LATINA Style Inc. Announces the 2021 LATINA Style 50 Report
Published: 2021-09-17 (Crawled : 19:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
| Email alert
Add to watchlist
GM | News 0 d | $42.44 -0.05% 0.0% 14M
|
Consumer Durables
| Email alert
Add to watchlist
MCK | $518.81 -1.35% 0.0% 630K
|
Distribution Services
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
MET | $69.95 1.49% 0.0% 2.7M
|
Finance
| Email alert
Add to watchlist
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
| Email alert
Add to watchlist
F | $12.06 0.17% 0.08% 40M
|
Consumer Durables
| Email alert
Add to watchlist
STT 4 | $73.04 0.32% 0.15% 1.7M
|
Finance
| Email alert
Add to watchlist
MAR | $236.27 -0.92% -0.93% 1.8M
|
Consumer Services
| Email alert
Add to watchlist
WFC | $58.74 2.73% -0.05% 24M
|
Finance
| Email alert
Add to watchlist
AFL | News | $80.98 0.9% 0.0% 2.1M
|
Finance
| Email alert
Add to watchlist
Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Disea...
Published: 2021-09-17 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
research
Worldwide Short Bowel Syndrome Industry to 2026 - Development of Short Bowel Syndrome Drugs is at a Nascent Stage Presents Opportunities
Published: 2021-09-17 (Crawled : 17:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
drug syndros
BioSpace Movers & Shakers, Sept. 17
Published: 2021-09-17 (Crawled : 17:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
PODD | $164.71 -0.93% -0.94% 590K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
space spac
Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Diseases Gets More Support
Published: 2021-09-17 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
disease research
Global Industry Analysts Predicts the World Natural and Organic Skin Care Products Market to Reach $9.7 Billion by 2026
Published: 2021-09-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
skin
Research Roundup: Biogen’s Non-Opioid Pain Drug Hits Mark in Small Fiber Neuropathy
Published: 2021-09-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
opioid drug research
Research Roundup: Biogen’s Non-Opioid Pain Drug Hits Mark in Small Fiber Neur...
Published: 2021-09-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
opioid drug research
Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
Published: 2021-09-17 (Crawled : 12:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
phase 1 results phase 1b phase 2b urothelial carcinoma pd-1 inhibitor
Mat Bisher Joins DDB New York as Chief Creative Officer, Further Fueling the Power of Creativity within the New York Office
Published: 2021-09-17 (Crawled : 01:00) - prnewswire.com
OMC | $91.5 -1.03% 0.0% 1.6M
|
Commercial Services
|
| O: 0.33%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.